Alector Inc
NASDAQ:ALEC 4:00:00 PM EDT
Market Cap (Intraday) | 576.39M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $6.10 |
50-Day MA | $6.28 |
200-Day MA | $6.35 |
Alector Inc Stock, NASDAQ:ALEC
131 Oyster Point Boulevard, Suite 600, South San Francisco, California 94080-2029
United States of America
Phone: +1.415.231.5660
Number of Employees: 244
Description
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.